TY - JOUR
T1 - Fluoroapatite glass-ceramic coating on alumina
T2 - Surface behavior with biological fluids
AU - Bosetti, M.
AU - Vernè, E.
AU - Brovarone, C. Vitale
AU - Moisescu, C.
AU - Sabbatini, M.
AU - Cannas, M.
PY - 2003/9/1
Y1 - 2003/9/1
N2 - The results of a surface analysis performed on a fluoroapatite-based glass ceramic (SAF) also coating a full-density α-alumina substrate (SAF-alumina coating) are presented. These two materials have also been evaluated after soaking in simulated body fluid to understand their ability to induce hydroxyapatite growth on them. Aiming to understand the fluoroapatite glass-ceramic interaction with some plasma proteins, in the second part of this study, fibronectin, albumin, immunoglobulin G, IgA, and complement factor C3c SAF binding have been evaluated; surface activity on complement activation has also been quantified. SAF-alumina coating provides good sites for the nucleation and growth of an apatite layer, equivalent to the mineral component of bone and binds preferentially plasma fibronectin, which is well known to enhance cell adhesion and spreading. Moreover, SAF-alumina coating reduces alumina complement activation directly or via reduced IgA binding. Alumina was shown to bind the same C3 fragments as Zymosan, used as complement activating control, and to induce increased levels of serum soluble iC3b and Bb. A mechanical resistant material with enhanced bioactivity, bone integration, and reduced inflammatory potential respect to alumina has been obtained.
AB - The results of a surface analysis performed on a fluoroapatite-based glass ceramic (SAF) also coating a full-density α-alumina substrate (SAF-alumina coating) are presented. These two materials have also been evaluated after soaking in simulated body fluid to understand their ability to induce hydroxyapatite growth on them. Aiming to understand the fluoroapatite glass-ceramic interaction with some plasma proteins, in the second part of this study, fibronectin, albumin, immunoglobulin G, IgA, and complement factor C3c SAF binding have been evaluated; surface activity on complement activation has also been quantified. SAF-alumina coating provides good sites for the nucleation and growth of an apatite layer, equivalent to the mineral component of bone and binds preferentially plasma fibronectin, which is well known to enhance cell adhesion and spreading. Moreover, SAF-alumina coating reduces alumina complement activation directly or via reduced IgA binding. Alumina was shown to bind the same C3 fragments as Zymosan, used as complement activating control, and to induce increased levels of serum soluble iC3b and Bb. A mechanical resistant material with enhanced bioactivity, bone integration, and reduced inflammatory potential respect to alumina has been obtained.
KW - Alumina
KW - Complement activation
KW - Fluoroapatite glass-ceramic
KW - Plasma protein binding
KW - Surface behavior
UR - http://www.scopus.com/inward/record.url?scp=0344738720&partnerID=8YFLogxK
U2 - 10.1002/jbm.a.10030
DO - 10.1002/jbm.a.10030
M3 - Article
SN - 0021-9304
VL - 66
SP - 615
EP - 621
JO - Journal of Biomedical Materials Research - Part A
JF - Journal of Biomedical Materials Research - Part A
IS - 3
ER -